TNF and lung disorder: Glycolytic-driven activation of immune cells might contribute to epithelial damage in pulmonary diseases, for example via released cytokines such as tumor necrosis factor (TNF), causing loosening of tight junction and cell death (40, 41), which can be defined as a metabolic-driven injury.